Schulman, S <br/><br/>
Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience.  [electronic resource] 

 -  Thrombosis and haemostasis  Sep 1994 
 - 403-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal--immunology<br/>Blood Loss, Surgical--prevention & control<br/>Child<br/>Child, Preschool<br/>Chromatography, Affinity<br/>Drug Contamination<br/>Drug Stability<br/>Environment, Controlled<br/>Escherichia coli--growth & development<br/>Factor VIII--administration & dosage<br/>Hemophilia A--therapy<br/>Hemorrhage--etiology<br/>Humans<br/>Immunosorbent Techniques<br/>Infusion Pumps<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Polyvinyl Chloride<br/>Postoperative Complications--prevention & control<br/>Safety<br/>Staphylococcus aureus--growth & development<br/>Treatment Outcome